Novavax Inc. sell JPMorgan Chase & Co.
Start price
18.11.25
/
50%
€5.63
Target price
18.11.26
€5.18
Performance (%)
30.72%
Price
13:05
€7.36
Summary
This prediction is currently active. The price for Novavax Inc. has massively increased, which is bad news for the SELL prediction by JPMorgan_Chase___Co_. This prediction currently runs until 18.11.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Novavax Inc. | -9.074% | -9.074% |
| iShares Core DAX® | -0.436% | 1.181% |
| iShares Nasdaq 100 | 0.854% | 1.475% |
| iShares Nikkei 225® | 2.652% | 6.401% |
| iShares S&P 500 | 1.190% | 1.169% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Novavax Inc. diskutieren
Novavax (NASDAQ:NVAX) had its price target lowered by analysts at JPMorgan Chase & Co. from $7.00 to $6.00. They now have an "underweight" rating on the stock.
Ratings data for NVAX provided by MarketBeat